Article info

Download PDFPDF

Original research
Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials

Authors

  1. Correspondence to Dr Masatoyo Nishizawa, Department of Neurology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan; nishizawamasatoyo{at}gmail.com
View Full Text

Citation

Nishizawa M, Onodera O, Hirakawa A on behalf of the Rovatirelin Study Group, et al
Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials

Publication history

  • Received October 4, 2019
  • Revised December 22, 2019
  • Accepted December 25, 2019
  • First published January 14, 2020.
Online issue publication 
February 13, 2020

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.